ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,091 | +2.6% | 42,617 | +6.5% | 0.00% | +50.0% |
Q2 2023 | $1,063 | -99.7% | 40,000 | +53.3% | 0.00% | +100.0% |
Q2 2022 | $402,000 | -44.1% | 26,100 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $719,000 | -21.8% | 26,100 | +10.1% | 0.00% | 0.0% |
Q4 2021 | $920,000 | -14.8% | 23,700 | +2.6% | 0.00% | -33.3% |
Q3 2021 | $1,080,000 | +285.7% | 23,100 | +185.2% | 0.00% | +200.0% |
Q2 2021 | $280,000 | -10.8% | 8,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $314,000 | -8.5% | 8,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $343,000 | – | 8,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |